Financhill
Sell
37

CLPT Quote, Financials, Valuation and Earnings

Last price:
$14.51
Seasonality move :
17.82%
Day range:
$14.01 - $14.57
52-week range:
$9.76 - $30.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.72x
P/B ratio:
25.73x
Volume:
397.7K
Avg. volume:
698.5K
1-year change:
-1.78%
Market cap:
$408.4M
Revenue:
$31.4M
EPS (TTM):
-$0.83

Earnings Data

Next earnings date for CLPT
Feb 25
2026
Most recent earnings per share
-$0.21
Missed by $0.01
(Nov 6/2025)
Consensus Estimate
-$0.20
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CLPT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $10.1M -- -- -$0.20 --
11/06/2025 Q3 $9.6M $8.9M -$0.21 -$0.20 -$0.01
08/12/2025 Q2 $9.2M $9.2M -$0.21 -$0.20 -$0.01
05/06/2025 Q1 $8.2M $8.5M -$0.22 -$0.16 -$0.06
02/26/2025 Q4 $8.2M $7.8M -$0.20 -$0.16 -$0.03
11/07/2024 Q3 $7.8M $8.1M -$0.18 -$0.17 -$0.01
08/07/2024 Q2 $7.3M $7.9M -$0.16 -$0.18 $0.02
05/07/2024 Q1 $7M $7.6M -$0.16 -$0.19 $0.03
03/12/2024 Q4 $6.5M $6.8M -$0.19 -$0.20 $0.02
11/09/2023 Q3 -- $5.8M -$0.20 -- --
08/08/2023 Q2 -- $6M -$0.29 -- --
05/11/2023 Q1 -- $5.4M -$0.23 -- --
03/01/2023 Q4 -- $5.2M -$0.18 -- --
11/08/2022 Q3 -- $5.1M -$0.15 -- --
08/09/2022 Q2 -- $5.2M -$0.18 -- --
05/11/2022 Q1 -- $5M -$0.17 -- --
03/01/2022 Q4 -- $4.3M -$0.18 -- --
11/09/2021 Q3 -- $4.6M -$0.18 -- --
08/10/2021 Q2 -- $3.4M -$0.17 -- --
05/11/2021 Q1 -- $4M -$0.13 -- --
03/04/2021 Q4 -- $3.7M -$0.09 -- --
11/10/2020 Q3 -- $3.5M -$0.09 -- --
08/12/2020 Q2 -- $2.5M -$0.11 -- --
05/12/2020 Q1 -- $3.1M -$0.13 -- --
12/31/2019 Q4 -- $3.2M -$0.11 -- --
09/30/2019 Q3 -- $2.9M -$0.08 -- --
06/30/2019 Q2 -- $2.6M -$0.13 -- --
03/31/2019 Q1 -- $2.5M -$0.11 -- --
12/31/2018 Q4 -- $2.3M -$0.11 -- --
09/30/2018 Q3 -- $1.8M -$0.13 -- --
06/30/2018 Q2 -- $1.6M -$0.17 -- --
03/31/2018 Q1 -- $1.6M -$0.15 -- --
12/31/2017 Q4 -- $1.7M -$0.20 -- --
09/30/2017 Q3 -- $1.7M -$0.14 -- --
06/30/2017 Q2 -- $2M -$0.32 -- --
03/31/2017 Q1 -- $2M -$0.46 -- --
12/31/2016 Q4 -- $1.6M -$0.47 -- --
09/30/2016 Q3 -- $1.6M -$0.92 -- --
06/30/2016 Q2 -- $1.1M -$0.77 -- --
03/31/2016 Q1 -- $1.4M -$0.80 -- --
12/31/2015 Q4 -- -- -- -- --

Clearpoint Neuro, Inc. Earnings Questions

  • How Much did Clearpoint Neuro, Inc. Generate in Revenue Last Quarter?

    Clearpoint Neuro, Inc. reported $8.9M worth of top line sales in its most recent quarter.

  • Did Clearpoint Neuro, Inc. Beat Earnings Last Quarter?

    Clearpoint Neuro, Inc. announced earnings per share of -$0.21 which represents a miss of analyst forecast a -$0.20 per share.

  • Is Clearpoint Neuro, Inc. Profitable?

    Clearpoint Neuro, Inc. reported $5.6M that represents $0.20 per share over the last quarter.

  • What is the Analyst Consensus for Clearpoint Neuro, Inc. EPS Next Year?

    Clearpoint Neuro, Inc.'s earnings are forecast to decrease from -$0.70 per share to -$0.67 per share next year representing a decrease of -18.61%.

  • When is Clearpoint Neuro, Inc.'s Earnings Date?

    Clearpoint Neuro, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock